Small Molecule Induced Cell Rejuvenation via JAK-STAT Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for rejuvenating mesenchymal stem cells are limited by poor induction efficiency, genetic modification risks, and the aging of cells, which restricts their clinical application in reversing aging and repairing tissues.
Innovation Solution
A method involving the regulation of the JAK-STAT signaling pathway using small molecules to induce dedifferentiation of somatic cells, resulting in the preparation of rejuvenated mesenchymal stem cells (irMSCs) or regenerative fibroblasts (rFib), which can reverse aging and prolong lifespan.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If induced pluripotent stem (iPS) cells are prepared from elderly individuals, then young cells can be obtained for treatment, but the induction efficiency is poor and foreign genes are introduced causing genetic variation
Solution Approach 1:
The patent extracts and eliminates the harmful element of foreign gene introduction by using small molecule compounds instead of viral vectors or transgenic methods. The small molecules modulate endogenous signaling pathways (Wnt/β-catenin, JAK-STAT, PI3K/Akt) to induce dedifferentiation without introducing exogenous genetic material, thereby maintaining genomic stability while achieving reprogramming
Solution Approach 2:
The patent uses small molecule compounds as intermediaries to mediate the dedifferentiation process. These small molecules act as signaling modulators that temporarily activate specific pathways during induction, enabling efficient reprogramming without permanent genetic modification. The small molecules can be removed after induction, leaving no residual genetic impact
2Reliability
If genetic modification is used for cell rejuvenation, then young cells can be obtained, but off-target effects and tumorigenesis risks occur
Solution Approach 1:
The patent converts the natural aging process into a reversible state by targeting the underlying molecular mechanisms of aging. Instead of fighting against aging through aggressive genetic modification, the small molecules gently reprogram cells by modulating endogenous pathways that naturally decline with age, turning the aging process itself into a reversible phenomenon without introducing new hazards
Solution Approach 2:
The patent uses small molecule compounds that can be easily added and removed from cell cultures, replacing complex, permanent genetic modification systems. These small molecules serve as temporary, disposable induction agents that perform their function during the induction period and can be completely washed away, leaving no permanent alteration to the cell genome
3Productivity
If mesenchymal stem cells are used for treatment, then tissue repair can be achieved, but the cells become aged and lose function over time
Solution Approach 1:
The patent applies preliminary rejuvenation treatment to mesenchymal stem cells before they are used for therapeutic purposes. By treating aged MSCs with small molecule compounds that activate Wnt/β-catenin and other signaling pathways, the cells are reprogrammed to a younger state in advance, restoring their proliferative capacity, differentiation potential, and tissue repair functions before transplantation or application
Data Source
AI summary
A preparation method and applications of rejuvenated and regenerative fibroblasts, where the rejuvenated and regenerative fibroblasts are prepared from normal fibroblasts by inhibiting the JAK-STAT signaling pathway. The rejuvenated and regenerative fibroblasts are prepared by treating the target cells with a small molecular combination, a cytokine combination or a recombinant protein combination. This application further provides an application of the rejuvenated and regenerative fibroblasts in the reprogramming or rejuvenation of cells, tissues, organs and organisms.